Hearing loss (HL) in patients with systemic lupus erythematosus (SLE) has been widely reported, though the underlying mechanisms remain unclear. In this study, we demonstrate significant HL in an imiquimod-induced mouse model of SLE, accompanied by blood–labyrinth barrier (BLB) damage in the stria vascularis (SV). We found that cytotoxic CD8 + T lymphocytes and natural killer cells mediate BLB disruption, with granzyme b (Gzmb) acting as the primary factor inducing cell death of the cochlear capillary endothelial cells. Remarkably, inhibiting Gzmb by Serpinb9 significantly alleviates the elevations of hearing thresholds in imiquimod-induced SLE model mice, suggesting a therapeutic target for autoimmune-related HL. Our findings provide insights into the pathogenesis of SLE-related HL and propose Gzmb inhibition as a potential therapeutic strategy.
Sensorineural hearing loss, caused by irreversible hair cell (HC) loss, remains incurable due to the inability of the mammalian cochlea to regenerate HCs spontaneously. Although the combinatorial modulation of Notch and Wnt signaling robustly reprograms cochlear supporting cells to HCs in vitro, these strategies show limited success in vivo, which suggests that the native cochlear microenvironment imposes inhibitory cues. Here, we identify hypoxia-inducible factor 1α (HIF1α) as a critical barrier to HC reprogramming in vivo. We found that HIF1α accumulates in the basilar membrane of the intact cochlea, whereas ex vivo culture rapidly eliminates this accumulation. Mimicking the in vivo hypoxic state recapitulated the reprogramming blockade, hindering supporting cells from completing the fate transition to HCs. Mechanistically, HIF1α selectively suppressed Wnt signaling, as evidenced by the reduced expression of Wnt target genes and Wnt10a. Importantly, the pharmacological inhibition of HIF1α rescued the impaired reprogramming under hypoxia. These findings demonstrate that HIF1α accumulation in the hypoxic cochlear environment antagonizes Wnt-mediated HC differentiation, providing a mechanistic explanation for the failure of in vivo regeneration. Targeting HIF1α to restore supporting cell reprogramming competence within the hypoxic cochlear niche represents a promising, clinically translatable strategy for functional HC regeneration and hearing restoration.
13 October 2026 in Journal of Genetics and Genomics
Purpose: Laryngeal schwannoma is a rare condition with limited research. This case series presents cases of laryngeal schwannoma in our department with details on the surgical approaches and prognosis of patients, in order to add more evidence for this setting. Methods: The patients presented with symptoms that suggested diseases in the throat. These patients were examined by laryngoscopy, magnetic resonance imaging (MRI), and computed tomography (CT). Depending on the tumor size and location, trans-oral endoscopic (laser-assisted) resection, or open laryngeal surgery was applied. The open surgery was modified by splitting the thyroid cartilage plate in the middle (not entering the larynx) and separating the inner surface of the thyroid cartilage plate on the affected side. Results: The tumors of all patients were successfully removed. Then, these patients were followed up at the 1st, 3rd, and 6th month after surgery through clinic visits. Laryngoscopy, MRI, and CT were performed to examine the patients, and no recurrences were detected. Conclusion: The changes applied for the procedure presented in the present study have the potential to reduce recovery time and scarring, and help preserve throat function. The investigators consider these as potential alternatives to existing methods for treating laryngeal schwannomas. However, more research is required to refine the methods used to treat schwannomas and to ensure that patients receive the best care.